These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 36582474)

  • 21. Serological and molecular epidemiological outcomes after two decades of universal infant hepatitis B virus (HBV) vaccination in Nunavut, Canada.
    Huynh C; Minuk GY; Uhanova J; Baikie M; Wong T; Osiowy C
    Vaccine; 2017 Aug; 35(35 Pt B):4515-4522. PubMed ID: 28736196
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis B infection in rural Vietnam and the implications for a national program of infant immunization.
    Hipgrave DB; Nguyen TV; Vu MH; Hoang TL; Do TD; Tran NT; Jolley D; Maynard JE; Biggs BA
    Am J Trop Med Hyg; 2003 Sep; 69(3):288-94. PubMed ID: 14628946
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effectiveness of hepatitis B vaccine in toddlers based on the five-year period national basic health research (Riskesdas 2007, 2013 and 2018) in Indonesia.
    Lestari CSW; Dewi RM; Sunarno S; Hasugian AR; Handayani S; Maha MS; Panjaitan NSD; Ningrum N; Sari M; Fairuza F
    PeerJ; 2023; 11():e15199. PubMed ID: 37214093
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A retrospective study of hepatitis B vaccination in preterm birth and low birth weight infants born to hepatitis B surface antigen-positive mothers: Time to close the policy-practice gap.
    Qin W; Wang Y; Zhang X; Pan F; Cheng K; Sui H; Xie S
    Hum Vaccin Immunother; 2022 Dec; 18(7):2155390. PubMed ID: 36514905
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatitis B Surface Antigen Seroprevalence among Prevaccine and Vaccine Era Children in Bangladesh.
    Paul RC; Rahman M; Wiesen E; Patel M; Banik KC; Sharif AR; Sultana S; Rahman M; Liyanage J; Abeysinghe N; Kamili S; Murphy T; Luby SP; Mast EE
    Am J Trop Med Hyg; 2018 Sep; 99(3):764-771. PubMed ID: 30014817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effectiveness of hepatitis-B vaccination in Ivory Coast: the case of the Grand Bassam health district.
    Magoni M; Ekra KD; Aka LN; Sita KS; Kanga K
    Ann Trop Med Parasitol; 2009 Sep; 103(6):519-27. PubMed ID: 19695157
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis B immunization status and risk factors of people aged 1 to 69 in Huangpu District, Shanghai, China.
    Wang Y; Shu M; Chen J; Shen F; Ren H; Yu Y
    Front Public Health; 2023; 11():1302183. PubMed ID: 38179572
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Continuing risk for hepatitis B virus transmission among Southeast Asian infants in Louisiana.
    Mahoney FJ; Lawrence M; Scott C; Le Q; Lambert S; Farley TA
    Pediatrics; 1995 Dec; 96(6):1113-6. PubMed ID: 7491231
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early detection of chronic hepatitis B and risk factor assessment in Turkish migrants, Middle Limburg, Belgium.
    Koc ÖM; Kremer C; Hens N; Bielen R; Busschots D; Van Damme P; Robaeys G
    PLoS One; 2020; 15(7):e0234740. PubMed ID: 32716949
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Status and progress of hepatitis B control through vaccination in the South-East Asia Region, 1992-2015.
    Childs L; Roesel S; Tohme RA
    Vaccine; 2018 Jan; 36(1):6-14. PubMed ID: 29174317
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improved immunization practices reduce childhood hepatitis B infection in Tonga.
    Danielsson N; Fakakovikaetau T; Szegedi E
    Vaccine; 2009 Jul; 27(33):4462-7. PubMed ID: 19508908
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of HBV and HCV infections, Bhutan, 2017: Progress and next steps.
    Tshering N; Dhakal GP; Wangchuk U; Wangdi S; Khandu L; Pelden S; Nogareda F; Patel MK; Hutin YJF; Wannemuehler K; Rewari BB; Wangchuk S
    BMC Infect Dis; 2020 Jul; 20(1):485. PubMed ID: 32641006
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Residual risk of mother-to-child transmission of hepatitis B virus infection despite timely birth-dose vaccination in Cameroon (ANRS 12303): a single-centre, longitudinal observational study.
    Shimakawa Y; Veillon P; Birguel J; Pivert A; Sauvage V; Guillou-Guillemette HL; Roger S; Njouom R; Ducancelle A; Amta P; Huraux JM; Adoukara JP; Lunel-Fabiani F
    Lancet Glob Health; 2022 Apr; 10(4):e521-e529. PubMed ID: 35183302
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Preliminary analysis on the prevalence and causes of breakthrough hepatitis B virus infection among children in Shandong province, China].
    Zhang L; Yan BY; Li MS; Song LZ; Lü JJ; Xu Q; Xu AQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2013 Oct; 47(10):933-9. PubMed ID: 24378135
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of the implementation of a vaccination strategy on hepatitis B virus infections in China over a 20-year period.
    Luo Z; Li L; Ruan B
    Int J Infect Dis; 2012 Feb; 16(2):e82-8. PubMed ID: 22178658
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Minimization of hepatitis B infection by a 25-year universal vaccination program.
    Ni YH; Chang MH; Wu JF; Hsu HY; Chen HL; Chen DS
    J Hepatol; 2012 Oct; 57(4):730-5. PubMed ID: 22668640
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis B vaccination in children: the Taiwan experience.
    Ni YH; Chen DS
    Pathol Biol (Paris); 2010 Aug; 58(4):296-300. PubMed ID: 20116181
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early childhood transmission of hepatitis B prior to the first hepatitis B vaccine dose is rare among babies born to HIV-infected and non-HIV infected mothers in Gulu, Uganda.
    Seremba E; Van Geertruyden JP; Ssenyonga R; Opio CK; Kaducu JM; Sempa JB; Colebunders R; Ocama P
    Vaccine; 2017 May; 35(22):2937-2942. PubMed ID: 28434689
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Survey of hepatitis B virus infection status after 35 years of universal vaccination implementation in Taiwan.
    Chang KC; Chang MH; Chen HL; Cheng FW; Wu JF; Su WJ; Hsu HY; Ni YH
    Liver Int; 2024 Aug; 44(8):2054-2062. PubMed ID: 38700381
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protective effect of vaccinating infants with a 5 µg recombinant yeast-derived hepatitis B vaccine and the need for a booster dose in China.
    Miao N; Zheng H; Sun X; Zhang G; Wang F
    Sci Rep; 2020 Oct; 10(1):18155. PubMed ID: 33097788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.